Shannon N. Westin, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the future directions of the Phase III E/GOG-3041/ENGOT-EN10 (NCT04269200) trial, as well as the current areas of interest in endometrial cancer research. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.